|
1
|
Reik W and Walter J: Genomic imprinting:
Parental influence on the genome. Nat Rev Genet. 2:21–32. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Choufani S, Shuman C and Weksberg R:
Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet.
154C:343–354. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jacob KJ, Robinson WP and Lefebvre L:
Beckwith-Wiedemann and Silver-Russell syndromes: Opposite
developmental imbalances in imprinted regulators of placental
function and embryonic growth. Clin Genet. 84:326–334. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Weksberg R, Nishikawa J, Caluseriu O, Fei
YL, Shuman C, Wei C, Steele L, Cameron J, Smith A, Ambus I, et al:
Tumor development in the Beckwith-Wiedemann syndrome is associated
with a variety of constitutional molecular 11p15 alterations
including imprinting defects of KCNQ1OT1. Hum Mol Genet.
10:2989–3000. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
DeBaun MR and Tucker MA: Risk of cancer
during the first four years of life in children from The
Beckwith-Wiedemann Syndrome Registry. J Pediatr. 132:398–400. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rump P, Zeegers MP and van Essen AJ: Tumor
risk in Beckwith-Wiedemann syndrome: A review and meta-analysis. Am
J Med Genet A. 136:95–104. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Higashimoto K, Soejima H, Saito T, Okumura
K and Mukai T: Imprinting disruption of the CDKN1C/KCNQ1OT1 domain:
The molecular mechanisms causing Beckwith-Wiedemann syndrome and
cancer. Cytogenet Genome Res. 113:306–312. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Scott RH, Douglas J, Baskcomb L, Nygren
AO, Birch JM, Cole TR, Cormier-Daire V, Eastwood DM, Garcia-Minaur
S, Lupunzina P, et al: Methylation-specific multiplex
ligation-dependent probe amplification (MS-MLPA) robustly detects
and distinguishes 11p15 abnormalities associated with overgrowth
and growth retardation. J Med Genet. 45:106–113. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Weksberg R, Shuman C and Beckwith JB:
Beckwith-Wiedemann syndrome. Eur J Hum Genet. 18:8–14. 2010.
View Article : Google Scholar :
|
|
10
|
Du M, Zhou W, Beatty LG, Weksberg R and
Sadowski PD: The KCNQ1OT1 promoter, a key regulator of genomic
imprinting in human chromosome 11p15.5. Genomics. 84:288–300. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kanduri C: Kcnq1ot1: A chromatin
regulatory RNA. Semin Cell Dev Biol. 22:343–350. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mohammad F, Pandey GK, Mondal T, Enroth S,
Redrup L, Gyllensten U and Kanduri C: Long noncoding RNA-mediated
maintenance of DNA methylation and transcriptional gene silencing.
Development. 139:2792–2803. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mancini-Dinardo D, Steele SJ, Levorse JM,
Ingram RS and Tilghman SM: Elongation of the Kcnq1ot1 transcript is
required for genomic imprinting of neighboring genes. Genes Dev.
20:1268–1282. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chiesa N, De Crescenzo A, Mishra K, Perone
L, Carella M, Palumbo O, Mussa A, Sparago A, Cerrato F, Russo S, et
al: The KCNQ1OT1 imprinting control region and non-coding RNA: New
properties derived from the study of Beckwith-Wiedemann syndrome
and Silver-Russell syndrome cases. Hum Mol Genet. 21:10–25. 2012.
View Article : Google Scholar
|
|
15
|
Zhang P, Wong C, DePinho RA, Harper JW and
Elledge SJ: Cooperation between the Cdk inhibitors p27(KIP1) and
p57(KIP2) in the control of tissue growth and development. Genes
Dev. 12:3162–3167. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee MP, DeBaun MR, Mitsuya K, Galonek HL,
Brandenburg S, Oshimura M and Feinberg AP: Loss of imprinting of a
paternally expressed transcript, with antisense orientation to
KVLQT1, occurs frequently in Beckwith-Wiedemann syndrome and is
independent of insulin-like growth factor II imprinting. Proc Natl
Acad Sci USA. 96:5203–5208. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Diaz-Meyer N, Day CD, Khatod K, Maher ER,
Cooper W, Reik W, Junien C, Graham G, Algar E, Der Kaloustian VM,
et al: Silencing of CDKN1C (p57KIP2) is associated with
hypomethylation at KvDMR1 in Beckwith-Wiedemann syndrome. J Med
Genet. 40:797–801. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nakano S, Murakami K, Meguro M, Soejima H,
Higashimoto K, Urano T, Kugoh H, Mukai T, Ikeguchi M and Oshimura
M: Expression profile of LIT1/KCNQ1OT1 and epigenetic status at the
KvDMR1 in colorectal cancers. Cancer Sci. 97:1147–1154. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Soejima H, Nakagawachi T, Zhao W,
Higashimoto K, Urano T, Matsukura S, Kitajima Y, Takeuchi M,
Nakayama M, Oshimura M, et al: Silencing of imprinted CDKN1C gene
expression is associated with loss of CpG and histone H3 lysine 9
methylation at DMR-LIT1 in esophageal cancer. Oncogene.
23:4380–4388. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dervan PB: Molecular recognition of DNA by
small molecules. Bioorg Med Chem. 9:2215–2235. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Arcamone F, Penco S, Orezzi P, Nicolella V
and Pirelli A: Structure and synthesis of distamycin A. Nature.
203:1064–1065. 1964. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dervan PB and Edelson BS: Recognition of
the DNA minor groove by pyrrole-imidazole polyamides. Curr Opin
Struct Biol. 13:284–299. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bando T, Narita A, Saito I and Sugiyama H:
Molecular design of a pyrrole-imidazole hairpin polyamides for
effective DNA alkylation. Chemistry. 8:4781–4790. 2002. View Article : Google Scholar
|
|
24
|
Murty MS and Sugiyama H: Biology of
N-methylpyrrole-N-methylimidazole hairpin polyamide. Biol Pharm
Bull. 27:468–474. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wan J, Huang M, Zhao H, Wang C, Zhao X,
Jiang X, Bian S, He Y and Gao Y: A novel tetranucleotide repeat
polymorphism within KCNQ1OT1 confers risk for hepatocellular
carcinoma. DNA Cell Biol. 32:628–634. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vermes I, Haanen C, Steffens-Nakken H and
Reutelingsperger C: A novel assay for apoptosis. Flow cytometric
detection of phosphatidylserine expression on early apoptotic cells
using fluorescein labelled Annexin V. J Immunol Methods. 184:39–51.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Aubry JP, Blaecke A, Lecoanet-Henchoz S,
Jeannin P, Herbault N, Caron G, Moine V and Bonnefoy JY: Annexin V
used for measuring apoptosis in the early events of cellular
cytotoxicity. Cytometry. 37:197–204. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dobbelstein M and Moll U: Targeting
tumour-supportive cellular machineries in anticancer drug
development. Nat Rev Drug Discov. 13:179–196. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Farooqi AA, Rehman ZU and Muntane J:
Antisense therapeutics in oncology: Current status. Onco Targets
Ther. 7:2035–2042. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, Nagase H, Watanabe T, Nobusue H,
Suzuki T, Asami Y, Shinojima Y, Kawashima H, Takagi K, Mishra R, et
al: Inhibition of MMP-9 transcription and suppression of tumor
metastasis by pyrrole-imidazole polyamide. Cancer Sci. 101:759–766.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Matsuda H, Fukuda N, Ueno T, Katakawa M,
Wang X, Watanabe T, Matsui S, Aoyama T, Saito K, Bando T, et al:
Transcriptional inhibition of progressive renal disease by gene
silencing pyrrole-imidazole polyamide targeting of the transforming
growth factor-β1 promoter. Kidney Int. 79:46–56. 2011. View Article : Google Scholar
|
|
32
|
Du M, Beatty LG, Zhou W, Lew J, Schoenherr
C, Weksberg R and Sadowski PD: Insulator and silencer sequences in
the imprinted region of human chromosome 11p15.5. Hum Mol Genet.
12:1927–1939. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fitzpatrick GV, Soloway PD and Higgins MJ:
Regional loss of imprinting and growth deficiency in mice with a
targeted deletion of KvDMR1. Nat Genet. 32:426–431. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Arima T, Kamikihara T, Hayashida T, Kato
K, Inoue T, Shirayoshi Y, Oshimura M, Soejima H, Mukai T and Wake
N: ZAC, LIT1 (KCNQ1OT1) and p57KIP2 (CDKN1C) are in an imprinted
gene network that may play a role in Beckwith-Wiedemann syndrome.
Nucleic Acids Res. 33:2650–2660. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
LaBaer J, Garrett MD, Stevenson LF,
Slingerland JM, Sandhu C, Chou HS, Fattaey A and Harlow E: New
functional activities for the p21 family of CDK inhibitors. Genes
Dev. 11:847–862. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jin RJ, Lho Y, Wang Y, Ao M, Revelo MP,
Hayward SW, Wills ML, Logan SK, Zhang P and Matusik RJ:
Down-regulation of p57Kip2 induces prostate cancer in the mouse.
Cancer Res. 68:3601–3608. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guo H, Lv Y, Tian T, Hu TH, Wang WJ, Sui
X, Jiang L, Ruan ZP and Nan KJ: Downregulation of p57 accelerates
the growth and invasion of hepatocellular carcinoma.
Carcinogenesis. 32:1897–1904. 2011. View Article : Google Scholar : PubMed/NCBI
|
